BIOTEM Presentation

Your partner
in antibody production

BIOTEM, a company specialized in immunotechnologies since 1980, offers high value-added solutions for the custom development of antibodies and immunoassays (ELISA & LFIA). The company supports its clients by offering them tailor-made solutions for their R&D, Diagnostic and Therapeutic projects.

From the generation of unique monoclonal antibodies – by hybridoma and Phage Display technologies – through their production, characterization (affinity constants determinations and specificity studies, sequencing, stability studies,…) and immunoassay developments (ELISA & LFIA or Lateral Flow Immunoassays), BIOTEM offers a wide range of customized services.

40 Years
Expertise

Exclusive technologies & know-how

Dedicated
Team

With personalized support at each stage of the project

Quality &
reliability of results

ISO Standards & Results Commitments

100 %
Fee-for-service

No claim, No royalty, No follow-up right

97%

satisfaction

96%

success

BIOTEM Team

The entire team implements all the necessary means to ensure the success of each project and makes client satisfaction a priority! By making client listening a central element of the project, BIOTEM offers quality services and products in perfect harmony with their requirements.

BIOTEM’s
Commitments

Customer

Confidentiality &

Rules &

Results

Research &
Development

Besides its service activities, the company is heavily involved in various R&D programs, internally or through collaborative projects.
These programs aim to:

1

Optimize existing processes and develop new approaches for monoclonal antibody generations

2

Develop new monoclonal antibodies against relevant targets for diagnostic and therapeutic purposes

3

Propose innovative technologies to build new screening tools (rapid tests, biosensors, etc.)

4

Broaden its product catalog range for the scientific community and in the agri-food sector.

The research and development tax credit (“Crédit Impôt Recherche“) is the French government’s initiative to allow a deduction of a portion of the costs incurred from services in research and development provided by BIOTEM. This act applies to companies based in France.

BIOTEM has been accredited by the Ministry of Higher Education, Research and Innovation, so any organization using BIOTEM to carry out its research and development work will have the right to tax credits for their research investment.

For our clients, thanks to this accreditation, all the R&D projects entrusted to BIOTEM can open the right to a tax credit up to 50 % of the project cost. Consult the French tax administration to know more about your right to this credit.

DOWNLOAD THE CERTIFICATE